Feasibility study of outpatient chemotherapy with S-1+CDDP in gastric cancer patients
Not Applicable
- Conditions
- Gastric cancer
- Registration Number
- JPRN-UMIN000002685
- Lead Sponsor
- ational Cancer Center Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Not provided
Exclusion Criteria
1) History of hypersensitivity to S-1 or CDDP. 2) Receiving fluoropyrimidine preparation. 3) Receiving systemic steroid therapy. 4) Required to continue to take flucytosine, phenytoin, and warfarin. 5) Severe complications (ileus, bowel obstruction, interstitial lung disease, uncontrolled diabetes, severe arrhythmia, heart failure, renal failure, liver cirrhosis, active hepatitis, and so on). 6) Active ischemic heart disease. 7) Woman who are pregnant, lactating, or willing to get pregnant, or man who are willing to have unprotected intercourse. 8) Severe mental disorder. 9) Regarded as inadequate physical conditions by attending physician.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method